{
  "id": "mhgap#referral_12b1f396",
  "content": "combined with psychosocial interventions (see other treatment, please refer to recommendation PSY2.\nrecommendations in this module – namely PSY11).\nPSY5. Is antipsychotic medicine effective and safe for adolescents with\npsychotic disorders (including schizophrenia)?\nRecommendation (update): 5.1 Oral antipsychotic medicines – namely aripiprazole, olanzapine,\npaliperidone, quetiapine, risperidone – should be considered under\nspecialist supervision for adolescents with psychotic disorders (including\nschizophrenia), carefully balancing effectiveness, side-effects and individual\npreference.\nStrength of recommendation: Conditional\nCertainty of evidence: Low\n5.2 Clozapine should be considered for adolescents with a treatment-\nresistant psychotic disorder (including schizophrenia) under specialist\nsupervision, carefully balancing effectiveness, side-effects and individual\npreference.\nStrength of recommendation: Conditional\nCertainty of evidence: Low\nJustification y Clozapine was followed by (compared with\ny Data were extracted from an NMA on efficacy, placebo) olanzapine, molindone, risperidone,\nacceptability and tolerability of antipsychotics in lurasidone, aripiprazole, quetiapine, paliperidone\nchildren and adolescents with schizophrenia: Krause and asenapine. Overall, effect sizes were moderate\net al., 2018 (28 RCTs) (199). to large.\ny Few antipsychotics have been tested in children and y For quality of life, quetiapine and lurasidone were\nadolescents. The medicines mentioned above were significantly superior to placebo with small effects.",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "referral",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Referral combined with psychosocial interventions (see other treatment, please refer to recommendation PSY2.\nrecommendations in this module – namely PSY11).\nPSY5. Is antipsychotic medicine effective and safe for adolescents with\npsychotic disorders (including schizophrenia)?\nRecommendation (update): 5.1 Oral antipsychotic medicines – namely aripiprazole, olanzapine,\npaliperidone, quetiapine, risperidone – should be considered under\nspecialist supervision for adolescents with psychotic disorders (including\nschizophrenia), carefully balancing effectiveness, side-effects and individual\npreference.\nStrength of recommendation: Conditional\nCertainty of evidence: Low\n5.2 Clozapine should be considered for adolescents with a treatment-\nresistant psychotic disorder (including schizophrenia) under specialist\nsupervision, carefully balancing effectiveness, side-effects and individual\npreference.\nStrength of recommendation: Conditional\nCertainty of evidence: Low\nJustification y Clozapine was followed by (compared with\ny Data were extracted from an NMA on efficacy, placebo) olanzapine, molindone, risperidone,\nacceptability and tolerability of antipsychotics in lurasidone, aripiprazole, quetiapine, paliperidone\nchildren and adolescents with schizophrenia: Krause and asenapine. Overall, effect sizes were moderate\net al., 2018 (28 RCTs) (199). to large.\ny Few antipsychotics have been tested in children and y For quality of life, quetiapine and lurasidone were\nadolescents. The medicines mentioned above were significantly superior to placebo with small effects. Combined with psychosocial interventions (see other treatment, please refer to recommendation psy2. recommendations in this module – namely psy11)."
}